logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On April 10, NetEase Music (09899) spent HK$14.9998 million to repurchase 119,600 shares.

date
21:19 10/04/2026
avatar
GMT Eight
NetEase Cloud Music (09899) announced that it will repurchase 119,600 shares at a cost of 14,999.8 million Hong Kong dollars on April 10, 2026.
NETEASE MUSIC (09899) announced that it will spend 14.99 million Hong Kong dollars to repurchase 11.96 thousand shares on April 10, 2026.
Related Articles
HK Stock
China Railway Construction Corporation (01186): "CRCC YK25" and "CRCC YK26" will pay interest on April 21st.
HK Stock
Wanguo Gold GP (03939) founder Gao Mingqing increased his holdings by a total of 2.03 million shares.
HK Stock
REMEGEN (09995): The marketing application for Vedolizumab for the treatment of HER2-expressing urothelial carcinoma indication has been approved.
China Railway Construction Corporation (01186): "CRCC YK25" and "CRCC YK26" will pay interest on April 21st.
HK Stock
Wanguo Gold GP (03939) founder Gao Mingqing increased his holdings by a total of 2.03 million shares.
HK Stock
REMEGEN (09995): The marketing application for Vedolizumab for the treatment of HER2-expressing urothelial carcinoma indication has been approved.
HK Stock
RECOMMEND
Deloitte China Reports Three Mega Hong Kong IPOs Among Global Top Five In Q1
Deloitte China Reports Three Mega Hong Kong IPOs Among Global Top Five In Q1
icon
09/04/2026
Token Wave Reshapes China’s Internet Landscape
Token Wave Reshapes China’s Internet Landscape
icon
09/04/2026
State‑Owned Six Banks Saw Consumer Loan Balances Rise Over RMB 55 Billion Last Year, Five Banks Grew Above 16% — Will The Surge Continue In 2026?
State‑Owned Six Banks Saw Consumer Loan Balances Rise Over RMB 55 Billion Last Year, Five Banks Grew Above 16% — Will The Surge Continue In 2026?
icon
09/04/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.